Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 321

1.

IL-17-deficient allogeneic bone marrow transplantation prevents the induction of collagen-induced arthritis in DBA/1J mice.

Park MJ, Park HS, Oh HJ, Lim JY, Yoon BY, Kim HY, Cho ML, Cho SG.

Exp Mol Med. 2012 Nov 30;44(11):694-705. doi: 10.3858/emm.2012.44.11.078.

2.

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.

Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.

Arthritis Res. 1999;1(1):81-91. Epub 1999 Oct 26.

3.

Effect of bone marrow-derived CD11b(+)F4/80 (+) immature dendritic cells on the balance between pro-inflammatory and anti-inflammatory cytokines in DBA/1 mice with collagen-induced arthritis.

Fu J, Zhang L, Song S, Sheng K, Li Y, Li P, Song S, Wang Q, Chu J, Wei W.

Inflamm Res. 2014 May;63(5):357-67. doi: 10.1007/s00011-014-0707-7. Epub 2014 Jan 24.

PMID:
24458308
4.

Impact of Schistosoma japonicum infection on collagen-induced arthritis in DBA/1 mice: a murine model of human rheumatoid arthritis.

Song X, Shen J, Wen H, Zhong Z, Luo Q, Chu D, Qi Y, Xu Y, Wei W.

PLoS One. 2011;6(8):e23453. doi: 10.1371/journal.pone.0023453. Epub 2011 Aug 8.

5.

Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T.

Arthritis Rheum. 2008 Dec;58(12):3710-9. doi: 10.1002/art.24126.

6.

A proinflammatory role for Fas in joints of mice with collagen-induced arthritis.

Tu-Rapp H, Hammermüller A, Mix E, Kreutzer HJ, Goerlich R, Köhler H, Nizze H, Thiesen HJ, Ibrahim SM.

Arthritis Res Ther. 2004;6(5):R404-14. Epub 2004 Jul 19.

7.

IL-10-producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation.

Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, Wang S, Hua Z, Sun L, Srivastava G, Lau CS, Cao X, Lu L.

Am J Pathol. 2012 Jun;180(6):2375-85. doi: 10.1016/j.ajpath.2012.03.010. Epub 2012 Apr 23.

PMID:
22538089
8.

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.

Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.

Arthritis Rheum. 2004 Feb;50(2):650-9.

9.

Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collagen-induced arthritis.

Ferrari-Lacraz S, Zanelli E, Neuberg M, Donskoy E, Kim YS, Zheng XX, Hancock WW, Maslinski W, Li XC, Strom TB, Moll T.

J Immunol. 2004 Nov 1;173(9):5818-26.

10.

Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.

Ito Y, Usui T, Kobayashi S, Iguchi-Hashimoto M, Ito H, Yoshitomi H, Nakamura T, Shimizu M, Kawabata D, Yukawa N, Hashimoto M, Sakaguchi N, Sakaguchi S, Yoshifuji H, Nojima T, Ohmura K, Fujii T, Mimori T.

Arthritis Rheum. 2009 Aug;60(8):2294-303. doi: 10.1002/art.24687.

11.

Taurine chloramine inhibits osteoclastogenesis and splenic lymphocyte proliferation in mice with collagen-induced arthritis.

Wang Y, Cha YN, Kim KS, Kim C.

Eur J Pharmacol. 2011 Oct 1;668(1-2):325-30. doi: 10.1016/j.ejphar.2011.07.017. Epub 2011 Jul 28.

PMID:
21816143
12.

Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators.

Hartgring SA, Willis CR, Alcorn D, Nelson LJ, Bijlsma JW, Lafeber FP, van Roon JA.

Arthritis Rheum. 2010 Sep;62(9):2716-25. doi: 10.1002/art.27578.

13.

Effects of a novel tylophorine analog on collagen-induced arthritis through inhibition of the innate immune response.

You X, Pan M, Gao W, Shiah HS, Tao J, Zhang D, Koumpouras F, Wang S, Zhao H, Madri JA, Baker D, Cheng YC, Yin Z.

Arthritis Rheum. 2006 Mar;54(3):877-86.

14.

The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites.

Pineda MA, McGrath MA, Smith PC, Al-Riyami L, Rzepecka J, Gracie JA, Harnett W, Harnett MM.

Arthritis Rheum. 2012 Oct;64(10):3168-78. doi: 10.1002/art.34581.

15.

Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.

Lo CK, Lam QL, Sun L, Wang S, Ko KH, Xu H, Wu CY, Zheng BJ, Lu L.

Arthritis Rheum. 2008 Sep;58(9):2700-11. doi: 10.1002/art.23760.

16.
17.
18.

Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis.

Ju JH, Cho ML, Jhun JY, Park MJ, Oh HJ, Min SY, Cho YG, Hwang SY, Kwok SK, Seo SH, Yoon CH, Park SH, Kim HY.

Immunol Lett. 2008 Apr 15;117(1):16-25. doi: 10.1016/j.imlet.2007.09.011. Epub 2007 Oct 22.

PMID:
18242716
19.

Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma.

Kelchtermans H, Schurgers E, Geboes L, Mitera T, Van Damme J, Van Snick J, Uyttenhove C, Matthys P.

Arthritis Res Ther. 2009;11(4):R122. doi: 10.1186/ar2787. Epub 2009 Aug 17.

20.

SPA0355, a thiourea analogue, inhibits inflammatory responses and joint destruction in fibroblast-like synoviocytes and mice with collagen-induced arthritis.

Lee YR, Hwang JK, Lee HS, Cheon YJ, Ryu JH, Lee SI, Kwak HB, Lee SM, Kim JS, Park JW, Jeon R, Park BH.

Br J Pharmacol. 2011 Sep;164(2b):794-806. doi: 10.1111/j.1476-5381.2011.01441.x.

Supplemental Content

Support Center